| |
| | Catalent Pharmacy at Philadelphia: Supplying DTP Studies to Support Sponsors and Patients |
|
|
As part of Catalent’s FlexDirect® direct-to-patient solutions, sponsors are offered the unique ability to send clinical supplies to patients’ homes* from Catalent’s onsite pharmacy at its clinical packaging facility located in Philadelphia, Pennsylvania. |
|
|
Catalent’s Pharmacist-in-Charge (PIC) is licensed in all states that require a PIC to be registered, and is able to dispense clinical supplies directly to patients. The pharmacy itself is fully licensed and approved to ship to all 50 states plus DC, Puerto Rico, Guam, and the US Virgin Islands.
Sponsors can enjoy the convenience and efficiency of having their clinical supplies packaged in the same facility as the pharmacy, while knowing patients’ safety is ensured and their drugs are managed according to the study’s protocol and Pharmacy Agreement by the PIC. |
|
|
Additional benefits of Catalent’s in-house pharmacy include: |
|
|
Supplies remain flexible and onsite at Catalent Supplies are picked and packed in GMP conditions by Catalent trained professionals Catalent handles all courier booking and works with the courier to schedule the shipment with the patient Shipments can be tracked (blinded to the patient data) via our customer self-service portal
|
|
|
Contact us today to learn more about how our pharmacy can help support your direct-to-patient trial. |
|
|
| |
| |
Risk Mitigation in Direct-to-Patient Clinical Trials
This article explores how sponsors can proactively minimize risk in decentralized clinical studies, especially with direct-to-patient supply. Learn about the benefits of DTP and how these models can help sponsors efficiently supply their trials. |
|
|
| |
Understanding Options in Direct-to-Patient Clinical Supply
In this video, discover several approaches to direct-to-patient clinical supply that are in use today and how they can be used to flexibly support today’s decentralized clinical trials. |
|
|
